Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Epstein

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Oncology|January 1, 1991
GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcomaD T Scadden, H A Bering, J D Levine, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancerC Epstein, T Lynch, J Shefner, et al.
Synapse (New York, N.Y.)|October 1, 1995
Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic miceJ L Cadet, B Ladenheim, H Hirata, et al.
Journal of Interventional Cardiology|November 3, 2010
Elective coronary stenting increases fractional flow reserve in other arteries due to an increase in microvascular resistance: clinical implications for assessment of multivessel diseaseStephen P Hoole, Patrick M Heck, Andrew C Epstein, et al.
Translational Vision Science & Technology|May 27, 2016
Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis PigmentosaRithambara Ramachandran, Cindy X Cai, Dongwon Lee, et al.
Bone Marrow Transplantation|July 1, 1990
Hematopoietic growth factors in marrow transplantation and radiation injuryR Storb, F Appelbaum, J Nemunaitis, et al.
Bone Marrow Transplantation|February 1, 1991
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignanciesJ M Vose, P J Bierman, A Kessinger, et al.
Neuron|May 10, 2001
Epileptic seizures may begin hours in advance of clinical onset: a report of five patientsB Litt, R Esteller, J Echauz, et al.
Blood|July 1, 1990
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantationJ Nemunaitis, J W Singer, C D Buckner, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein DC Botas, F Poulain, J Akiyama, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|January 1, 1991
GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcomaD T Scadden, H A Bering, J D Levine, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancerC Epstein, T Lynch, J Shefner, et al.
Synapse (New York, N.Y.)|October 1, 1995
Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic miceJ L Cadet, B Ladenheim, H Hirata, et al.
Journal of Interventional Cardiology|November 3, 2010
Elective coronary stenting increases fractional flow reserve in other arteries due to an increase in microvascular resistance: clinical implications for assessment of multivessel diseaseStephen P Hoole, Patrick M Heck, Andrew C Epstein, et al.
Translational Vision Science & Technology|May 27, 2016
Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis PigmentosaRithambara Ramachandran, Cindy X Cai, Dongwon Lee, et al.
Bone Marrow Transplantation|July 1, 1990
Hematopoietic growth factors in marrow transplantation and radiation injuryR Storb, F Appelbaum, J Nemunaitis, et al.
Bone Marrow Transplantation|February 1, 1991
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignanciesJ M Vose, P J Bierman, A Kessinger, et al.
Neuron|May 10, 2001
Epileptic seizures may begin hours in advance of clinical onset: a report of five patientsB Litt, R Esteller, J Echauz, et al.
Blood|July 1, 1990
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantationJ Nemunaitis, J W Singer, C D Buckner, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein DC Botas, F Poulain, J Akiyama, et al.
Pageof 8